CTIC logo

CTI BioPharma (CTIC) Operating Profit

Annual Operating Profit

-$79.80 M
+$15.54 M+16.30%

December 31, 2022

Summary

Performance

1-Year Change

+16.3%

3-Year Change

-99.91%

5-Year Change

-101.92%

15-Year Change

-101.92%

CTIC Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$14.60 M

3-Year Low

-$95.33 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
CTIC previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
CTIC next annual earnings announcement has not yet been scheduled

OtherCTICprofitabilitymetrics:

Annual Operating Margin

-147.91%
CTIC annual operating profit margin is -147.91%

Annual Revenue

$53.95 M
CTIC annual revenue is $53.95 million

Annual Net Income

-$92.99 M
CTIC annual net profit is -$92.99 million

Annual EPS

-$0.81
CTIC annual earnings per share is -$0.81

Quarterly Operating Profit

-$9.23 M
+$4.36 M+32.10%

March 31, 2023

Summary

Performance

3-Month Change

+32.1%

1-Year Change

+73.7%

3-Year Change

+22.62%

5-Year Change

-112.92%

CTIC Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$15.95 M
CTIC quarterly operating income is currently -157.87% below its historical high of $15.95 million

3-Year Low

-$35.38 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
CTIC previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
CTIC next earnings announcement has not yet been scheduled

OtherCTICprofitabilitymetrics:

Quarterly Operating Margin

-38.28%
CTIC quarterly operating profit margin is -38.28%

Quarterly Revenue

$24.12 M
CTIC quarterly revenue is $24.12 million

Quarterly Net Income

-$13.42 M
CTIC quarterly net profit is -$13.42 million

Quarterly EPS

-$0.10
CTIC quarterly earnings per share is -$0.10

TTM Operating Profit

-$53.93 M
+$25.87 M+32.42%

March 31, 2023

Summary

Performance

3-Month Change

+32.42%

1-Year Change

+52.43%

3-Year Change

-28.07%

5-Year Change

-35.1%

CTIC TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$5.90 M

3-Year Low

-$113.36 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
CTIC previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
CTIC next earnings announcement has not yet been scheduled

OtherCTICprofitabilitymetrics:

Annual Operating Margin

-147.91%
CTIC annual operating profit margin is -147.91%

TTM Revenue

$75.77 M
CTIC TTM revenue is $75.77 million

TTM Net Income

-$69.24 M
CTIC TTM net profit is -$69.24 million

TTM EPS

-$0.58
CTIC TTM earnings per share is -$0.58

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

Annual Operating Profit

-$79.80 M
CTIC annual operating income is -$79.80 million

Annual Gross Profit

$50.43 M
CTIC annual gross profit is $50.43 million

Annual Operating Expenses

$130.23 M
CTIC annual total operating expenses is $130.23 million

CTIC Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+16.3%+73.7%+52.4%
3 y3 years-99.9%+22.6%-28.1%
5 y5 years-101.9%-112.9%-35.1%

CTIC Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+19.5%at high+283.2%at high+110.2%
5 y5-year+99.9%+19.5%at high+283.2%+35.1%+110.2%
alltimeall time+446.6%+92.3%-157.9%+435.1%+814.1%+184.5%

CTI BioPharma Operating Profit History

DateAnnualQuarterlyTTM
Mar 2023
-
-$9.23 M(-32.1%)
-$53.93 M(-32.4%)
Dec 2022
-$79.80 M(-16.3%)
-$13.60 M(+11.3%)
-$79.80 M(-21.4%)
Sep 2022
-
-$12.22 M(-35.3%)
-$101.58 M(-9.9%)
Jun 2022
-
-$18.88 M(-46.2%)
-$112.74 M(-0.5%)
Mar 2022
-
-$35.10 M(-0.8%)
-$113.36 M(+18.9%)
Dec 2021
-$95.33 M(+99.6%)
-$35.38 M(+51.3%)
-$95.33 M(+27.5%)
Sep 2021
-
-$23.38 M(+19.9%)
-$74.75 M(+19.8%)
Jun 2021
-
-$19.51 M(+14.3%)
-$62.42 M(+18.0%)
Mar 2021
-
-$17.07 M(+15.4%)
-$52.91 M(+10.8%)
Dec 2020
-$47.77 M(+19.7%)
-$14.80 M(+33.9%)
-$47.77 M(+12.5%)
Sep 2020
-
-$11.05 M(+10.5%)
-$42.45 M(+3.2%)
Jun 2020
-
-$10.00 M(-16.2%)
-$41.11 M(-2.4%)
Mar 2020
-
-$11.93 M(+25.9%)
-$42.11 M(+5.5%)
Dec 2019
-$39.92 M(+23.8%)
-$9.47 M(-2.5%)
-$39.92 M(+35.0%)
Sep 2019
-
-$9.71 M(-11.7%)
-$29.57 M(-14.6%)
Jun 2019
-
-$10.99 M(+12.9%)
-$34.63 M(-8.0%)
Mar 2019
-
-$9.74 M(-1221.9%)
-$37.64 M(+16.8%)
Dec 2018
-$32.24 M(-18.4%)
$868.00 K(-105.9%)
-$32.24 M(-31.1%)
Sep 2018
-
-$14.77 M(+5.5%)
-$46.81 M(+6.9%)
Jun 2018
-
-$14.00 M(+222.9%)
-$43.81 M(+78.5%)
Mar 2018
-
-$4.34 M(-68.4%)
-$24.54 M(-37.9%)
Dec 2017
-$39.52 M(-19.6%)
-$13.70 M(+16.5%)
-$39.52 M(+26.0%)
Sep 2017
-
-$11.77 M(-323.2%)
-$31.37 M(-35.0%)
Jun 2017
-
$5.27 M(-127.3%)
-$48.27 M(-33.5%)
Mar 2017
-
-$19.32 M(+247.6%)
-$72.61 M(+47.7%)
Dec 2016
-$49.16 M(-57.9%)
-$5.56 M(-80.6%)
-$49.16 M(-29.6%)
Sep 2016
-
-$28.66 M(+50.3%)
-$69.81 M(-4.5%)
Jun 2016
-
-$19.07 M(-562.0%)
-$73.10 M(-14.1%)
Mar 2016
-
$4.13 M(-115.8%)
-$85.06 M(-27.1%)
Dec 2015
-$116.67 M(+35.3%)
-$26.20 M(-18.0%)
-$116.67 M(-10.1%)
Sep 2015
-
-$31.95 M(+3.0%)
-$129.84 M(+43.6%)
Jun 2015
-
-$31.03 M(+12.9%)
-$90.41 M(+5.1%)
Mar 2015
-
-$27.48 M(-30.2%)
-$86.05 M(-0.2%)
Dec 2014
-$86.23 M(+107.7%)
-$39.37 M(-627.0%)
-$86.23 M(+135.1%)
Sep 2014
-
$7.47 M(-128.0%)
-$36.68 M(-38.4%)
Jun 2014
-
-$26.67 M(-3.6%)
-$59.58 M(+17.4%)
Mar 2014
-
-$27.66 M(-371.8%)
-$50.76 M(+22.2%)
Dec 2013
-$41.53 M(-58.7%)
$10.18 M(-166.0%)
-$41.53 M(-40.7%)
Sep 2013
-
-$15.43 M(-13.6%)
-$70.05 M(+1.0%)
Jun 2013
-
-$17.85 M(-3.1%)
-$69.33 M(-31.3%)
Mar 2013
-
-$18.43 M(+0.5%)
-$100.88 M(+0.3%)
Dec 2012
-$100.55 M(+37.4%)
-$18.34 M(+24.6%)
-$100.55 M(-2.5%)
Sep 2012
-
-$14.71 M(-70.2%)
-$103.12 M(-0.6%)
Jun 2012
-
-$49.40 M(+173.0%)
-$103.70 M(+45.6%)
Mar 2012
-
-$18.10 M(-13.5%)
-$71.22 M(-2.7%)
Dec 2011
-$73.19 M(-6.5%)
-$20.91 M(+36.8%)
-$73.19 M(+1.5%)
Sep 2011
-
-$15.29 M(-9.6%)
-$72.10 M(+3.3%)
Jun 2011
-
-$16.92 M(-15.7%)
-$69.81 M(-3.8%)
Mar 2011
-
-$20.07 M(+1.2%)
-$72.57 M(-7.3%)
Dec 2010
-$78.26 M(-10.9%)
-$19.82 M(+52.6%)
-$78.26 M(-7.3%)
Sep 2010
-
-$12.99 M(-34.0%)
-$84.44 M(-14.4%)
Jun 2010
-
-$19.68 M(-23.6%)
-$98.70 M(+1.9%)
Mar 2010
-
-$25.76 M(-1.0%)
-$96.89 M(+10.2%)
DateAnnualQuarterlyTTM
Dec 2009
-$87.82 M(+1.3%)
-$26.01 M(-4.6%)
-$87.95 M(+9.9%)
Sep 2009
-
-$27.25 M(+52.4%)
-$80.06 M(+13.3%)
Jun 2009
-
-$17.88 M(+6.4%)
-$70.67 M(-10.1%)
Mar 2009
-
-$16.81 M(-7.2%)
-$78.58 M(-9.4%)
Dec 2008
-$86.69 M(-19.9%)
-$18.12 M(+1.5%)
-$86.73 M(-14.3%)
Sep 2008
-
-$17.86 M(-30.8%)
-$101.23 M(-8.8%)
Jun 2008
-
-$25.79 M(+3.3%)
-$111.02 M(+1.4%)
Mar 2008
-
-$24.96 M(-23.5%)
-$109.53 M(+1.3%)
Dec 2007
-$108.17 M(+10.4%)
-$32.63 M(+18.1%)
-$108.17 M(+9.2%)
Sep 2007
-
-$27.64 M(+13.8%)
-$99.05 M(+3.8%)
Jun 2007
-
-$24.30 M(+2.9%)
-$95.44 M(+0.8%)
Mar 2007
-
-$23.60 M(+0.4%)
-$94.68 M(-3.0%)
Dec 2006
-$98.01 M(+118.0%)
-$23.51 M(-2.1%)
-$97.57 M(+67.9%)
Sep 2006
-
-$24.02 M(+2.0%)
-$58.10 M(+104.4%)
Jun 2006
-
-$23.54 M(-11.1%)
-$28.43 M(-20.4%)
Mar 2006
-
-$26.50 M(-266.1%)
-$35.70 M(-20.6%)
Dec 2005
-$44.95 M(-70.7%)
$15.95 M(+182.1%)
-$44.95 M(-55.7%)
Sep 2005
-
$5.66 M(-118.4%)
-$101.55 M(-26.8%)
Jun 2005
-
-$30.81 M(-13.8%)
-$138.69 M(-3.7%)
Mar 2005
-
-$35.75 M(-12.0%)
-$143.99 M(-6.2%)
Dec 2004
-$153.45 M(+25.2%)
-$40.64 M(+29.1%)
-$153.45 M(+4.3%)
Sep 2004
-
-$31.48 M(-12.8%)
-$147.10 M(+1.2%)
Jun 2004
-
-$36.12 M(-20.1%)
-$145.39 M(+4.9%)
Mar 2004
-
-$45.21 M(+31.8%)
-$138.56 M(+13.0%)
Dec 2003
-$122.58 M(+24.1%)
-$34.29 M(+15.2%)
-$122.58 M(+10.3%)
Sep 2003
-
-$29.77 M(+1.6%)
-$111.13 M(+1.1%)
Jun 2003
-
-$29.29 M(+0.2%)
-$109.90 M(+4.0%)
Mar 2003
-
-$29.23 M(+28.0%)
-$105.67 M(+7.0%)
Dec 2002
-$98.79 M(+18.3%)
-$22.84 M(-20.0%)
-$98.79 M(-7.4%)
Sep 2002
-
-$28.54 M(+13.9%)
-$106.73 M(+7.1%)
Jun 2002
-
-$25.06 M(+12.1%)
-$99.67 M(+8.4%)
Mar 2002
-
-$22.35 M(-27.4%)
-$91.98 M(+10.2%)
Dec 2001
-$83.48 M(+49.3%)
-$30.78 M(+43.2%)
-$83.49 M(+18.8%)
Sep 2001
-
-$21.49 M(+23.7%)
-$70.25 M(+10.8%)
Jun 2001
-
-$17.37 M(+25.4%)
-$63.37 M(+8.9%)
Mar 2001
-
-$13.85 M(-21.0%)
-$58.21 M(+4.5%)
Dec 2000
-$55.90 M(+49.5%)
-$17.54 M(+20.0%)
-$55.71 M(+19.4%)
Sep 2000
-
-$14.62 M(+19.8%)
-$46.68 M(+10.7%)
Jun 2000
-
-$12.20 M(+7.5%)
-$42.16 M(+4.7%)
Mar 2000
-
-$11.36 M(+33.6%)
-$40.26 M(+7.6%)
Dec 1999
-$37.40 M(+35.5%)
-$8.50 M(-15.8%)
-$37.40 M(+0.5%)
Sep 1999
-
-$10.10 M(-1.9%)
-$37.20 M(+11.7%)
Jun 1999
-
-$10.30 M(+21.2%)
-$33.30 M(+15.2%)
Mar 1999
-
-$8.50 M(+2.4%)
-$28.90 M(+5.1%)
Dec 1998
-$27.60 M(+7.8%)
-$8.30 M(+33.9%)
-$27.50 M(-3.5%)
Sep 1998
-
-$6.20 M(+5.1%)
-$28.50 M(+4.8%)
Jun 1998
-
-$5.90 M(-16.9%)
-$27.20 M(+1.1%)
Mar 1998
-
-$7.10 M(-23.7%)
-$26.90 M(+4.7%)
Dec 1997
-$25.60 M(+75.3%)
-$9.30 M(+89.8%)
-$25.70 M(+56.7%)
Sep 1997
-
-$4.90 M(-12.5%)
-$16.40 M(+42.6%)
Jun 1997
-
-$5.60 M(-5.1%)
-$11.50 M(+94.9%)
Mar 1997
-
-$5.90 M
-$5.90 M
Dec 1996
-$14.60 M
-
-

FAQ

  • What is CTI BioPharma annual operating income?
  • What is the all time high annual operating profit for CTI BioPharma?
  • What is CTI BioPharma annual operating profit year-on-year change?
  • What is CTI BioPharma quarterly operating income?
  • What is the all time high quarterly operating profit for CTI BioPharma?
  • What is CTI BioPharma quarterly operating profit year-on-year change?
  • What is CTI BioPharma TTM operating income?
  • What is the all time high TTM operating profit for CTI BioPharma?
  • What is CTI BioPharma TTM operating profit year-on-year change?

What is CTI BioPharma annual operating income?

The current annual operating profit of CTIC is -$79.80 M

What is the all time high annual operating profit for CTI BioPharma?

CTI BioPharma all-time high annual operating income is -$14.60 M

What is CTI BioPharma annual operating profit year-on-year change?

Over the past year, CTIC annual operating income has changed by +$15.54 M (+16.30%)

What is CTI BioPharma quarterly operating income?

The current quarterly operating profit of CTIC is -$9.23 M

What is the all time high quarterly operating profit for CTI BioPharma?

CTI BioPharma all-time high quarterly operating income is $15.95 M

What is CTI BioPharma quarterly operating profit year-on-year change?

Over the past year, CTIC quarterly operating income has changed by +$25.87 M (+73.70%)

What is CTI BioPharma TTM operating income?

The current TTM operating profit of CTIC is -$53.93 M

What is the all time high TTM operating profit for CTI BioPharma?

CTI BioPharma all-time high TTM operating income is -$5.90 M

What is CTI BioPharma TTM operating profit year-on-year change?

Over the past year, CTIC TTM operating income has changed by +$59.43 M (+52.43%)